Willow Biosciences Inc - Asset Resilience Ratio

Latest as of March 2025: 0.86%

Willow Biosciences Inc (WLLW) has an Asset Resilience Ratio of 0.86% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Willow Biosciences Inc (WLLW) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CA$20.00K

≈ $14.47K USD Cash + Short-term Investments

Total Assets

CA$2.31 Million

≈ $1.67 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Willow Biosciences Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Willow Biosciences Inc.

Liquid Assets Composition Over Time

This chart breaks down Willow Biosciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore WLLW long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$20.00K	0.86%
Total Liquid Assets	CA$20.00K	0.86%

Asset Resilience Insights

Limited Liquidity: Willow Biosciences Inc maintains only 0.86% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Willow Biosciences Inc Industry Peers by Asset Resilience Ratio

Compare Willow Biosciences Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Willow Biosciences Inc (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Willow Biosciences Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.80%	CA$20.00K ≈ $14.47K	CA$2.49 Million ≈ $1.80 Million	+0.50pp
2023-12-31	0.30%	CA$20.00K ≈ $14.47K	CA$6.67 Million ≈ $4.83 Million	-82.50pp
2022-12-31	82.80%	CA$15.03 Million ≈ $10.87 Million	CA$18.15 Million ≈ $13.13 Million	-5.15pp
2021-12-31	87.95%	CA$30.80 Million ≈ $22.28 Million	CA$35.02 Million ≈ $25.33 Million	+12.69pp
2020-12-31	75.27%	CA$16.46 Million ≈ $11.90 Million	CA$21.86 Million ≈ $15.82 Million	+16.75pp
2019-12-31	58.51%	CA$19.83 Million ≈ $14.34 Million	CA$33.88 Million ≈ $24.51 Million	+50.41pp
2016-12-31	8.10%	CA$137.61K ≈ $99.54K	CA$1.70 Million ≈ $1.23 Million	-7.42pp
2015-12-31	15.52%	CA$374.75K ≈ $271.09K	CA$2.42 Million ≈ $1.75 Million	--

pp = percentage points

About Willow Biosciences Inc

TO:WLLW Canada Drug Manufacturers - Specialty & Generic

Market Cap

$18.10 Million

CA$25.02 Million CAD

Market Cap Rank

#28607 Global

#1272 in Canada

Share Price

CA$0.17

Change (1 day)

+0.00%

52-Week Range

CA$0.17 - CA$0.17

All Time High

CA$2.08